ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Di Zhao
Matched on ORCID iD 0000-0001-6253-7127; OpenAlex author ID A5047200703. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Author Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. Co-author DOI 10.1038/s41586-026-11134-x↗
- Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance. Co-author DOI 10.1038/s41467-021-27349-7↗
- Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. Co-author DOI 10.1038/nature21052↗
- Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. Co-author DOI 10.1016/j.ccr.2013.02.005↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Haoqiang Ying · 3 shared papers, 2017–2026 · strength 0.37
- Paper Author Correction: Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. DOI 10.1038/s41586-026-11134-x↗
- Paper Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherap… DOI 10.1038/s41467-021-27349-7↗
- Paper Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. DOI 10.1038/nature21052↗
- Andrea Viale · 2 shared papers, 2017–2026 · strength 0.26
- Lifeng Yang · 2 shared papers, 2017–2026 · strength 0.26
- Huamin Wang · 2 shared papers, 2017–2026 · strength 0.26
- Ya’an Kang · 2 shared papers, 2017–2026 · strength 0.26
- Giannicola Genovese · 2 shared papers, 2017–2026 · strength 0.26
- Ronald Anthony Depinho · 2 shared papers, 2017–2026 · strength 0.26
- Jason B. Fleming · 2 shared papers, 2017–2026 · strength 0.26
- Prasenjit Dey · 2 shared papers, 2017–2026 · strength 0.26
- Anirban Maitra · 2 shared papers, 2017–2026 · strength 0.26
- Giulio Francesco Draetta · 2 shared papers, 2017–2026 · strength 0.26
- Deepak Nagrath · 2 shared papers, 2017–2026 · strength 0.26
- Tony Gutschner · 2 shared papers, 2017–2026 · strength 0.26
- Yalan Deng · 1 shared paper, 2021 · strength 0.10
- Wenjuan Yin · 1 shared paper, 2021 · strength 0.10
- Jun Yao · 1 shared paper, 2021 · strength 0.10
- Li Ma · 1 shared paper, 2021 · strength 0.10
- Mien‐Chie Hung · 1 shared paper, 2021 · strength 0.10
- Qinglei Hang · 1 shared paper, 2021 · strength 0.10
- Kun‐Liang Guan · 1 shared paper, 2013 · strength 0.03
- Qun‐Ying Lei · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.